Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down – What’s Next?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $9.43, but opened at $8.76. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.79, with a volume of 923 shares.

Analysts Set New Price Targets

Several research firms have commented on SGIOY. Jefferies Financial Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Finally, The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The company has a market capitalization of $14.94 billion, a price-to-earnings ratio of 10.98, a price-to-earnings-growth ratio of 3.55 and a beta of 0.08. The company has a quick ratio of 1.46, a current ratio of 1.58 and a debt-to-equity ratio of 0.01. The stock’s 50-day moving average price is $8.83 and its 200-day moving average price is $9.88.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%.The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $970.69 million. Equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.